MAPT and Alzheimer disease: Additionally, histone acetyltransferase and histone deacetylase inhibitors elevate histone acetylation, thereby exerting various positive effects on AD including preventing memory impairment, cognitive dysfunction, less deposition of the Aβ peptide, and reduced tau phosphorylation and formation of NFTs [77].